Stanley Laman Group Ltd. boosted its position in shares of Metlife Inc (NYSE:MET) by 6.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 32,545 shares of the financial services provider’s stock after buying an additional 1,937 shares during the period. Stanley Laman Group Ltd.’s holdings in Metlife were worth $1,645,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in MET. Intl Fcstone Inc. acquired a new position in shares of Metlife in the 2nd quarter valued at $383,000. PGGM Investments boosted its position in shares of Metlife by 2.3% in the 3rd quarter. PGGM Investments now owns 576,944 shares of the financial services provider’s stock valued at $29,972,000 after purchasing an additional 12,978 shares during the period. Hermes Investment Management Ltd. boosted its position in shares of Metlife by 30.0% in the 3rd quarter. Hermes Investment Management Ltd. now owns 283,208 shares of the financial services provider’s stock valued at $14,713,000 after purchasing an additional 65,438 shares during the period. Assenagon Asset Management S.A. boosted its position in shares of Metlife by 112.7% in the 3rd quarter. Assenagon Asset Management S.A. now owns 55,013 shares of the financial services provider’s stock valued at $2,858,000 after purchasing an additional 489,471 shares during the period. Finally, Robeco Institutional Asset Management B.V. boosted its position in shares of Metlife by 6.4% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 644,920 shares of the financial services provider’s stock valued at $33,504,000 after purchasing an additional 38,766 shares during the period. 76.25% of the stock is owned by institutional investors and hedge funds.
Shares of Metlife Inc (NYSE:MET) opened at $46.64 on Monday. Metlife Inc has a one year low of $43.38 and a one year high of $55.91. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.16 and a current ratio of 0.15. The firm has a market capitalization of $48,645.52, a PE ratio of 9.40, a PEG ratio of 1.05 and a beta of 1.31.
Metlife (NYSE:MET) last posted its quarterly earnings results on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($0.41). Metlife had a return on equity of 8.62% and a net margin of 5.69%. The firm had revenue of $15.79 billion for the quarter, compared to analysts’ expectations of $15.89 billion. During the same period last year, the business earned $1.28 earnings per share. equities research analysts anticipate that Metlife Inc will post 4.94 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Stockholders of record on Monday, February 5th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.43%. The ex-dividend date of this dividend is Friday, February 2nd. Metlife’s dividend payout ratio (DPR) is presently 46.92%.
MET has been the subject of a number of recent analyst reports. Argus increased their price target on Metlife from $55.00 to $60.00 and gave the company a “buy” rating in a research report on Monday, November 6th. ValuEngine lowered Metlife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 9th. Zacks Investment Research upgraded Metlife from a “hold” rating to a “buy” rating and set a $60.00 price target for the company in a research report on Thursday, November 9th. Wells Fargo & Co set a $62.00 price target on Metlife and gave the company a “buy” rating in a research report on Thursday, December 14th. Finally, Goldman Sachs Group reiterated a “buy” rating on shares of Metlife in a research report on Wednesday, January 31st. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and nine have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $57.77.
WARNING: “Stanley Laman Group Ltd. Increases Position in Metlife Inc (MET)” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/19/stanley-laman-group-ltd-increases-position-in-metlife-inc-met.html.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.